An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- 3 Humongous Health Care Stocks This Week
- 3 Pipeline Obesity Treatments You Should Watch
- Here's What This Big Market-Beater Has Been Buying and Selling
- Why the Supreme Court Was the Least of Monsanto's Concerns Yesterday
- 3 Stocks to Get on Your Watchlist
- America's 4th Best CEO Will Give You an Investing Edge